Winch Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Buy
17,345
+134
+0.8% +$3.5K 0.09% 82
2026
Q1
$483K Buy
17,211
+209
+1% +$5.56K 0.11% 76
2025
Q4
$423K Sell
17,002
-1,078
-6% -$27.2K 0.09% 78
2025
Q3
$461K Buy
18,080
+579
+3% +$14.3K 0.1% 73
2025
Q2
$424K Sell
17,501
-1,153
-6% -$26.9K 0.1% 74
2025
Q1
$473K Buy
18,654
+1,389
+8% +$36.3K 0.13% 68
2024
Q4
$458K Buy
17,265
+1,053
+6% +$28.6K 0.12% 66
2024
Q3
$469K Sell
16,212
-1,469
-8% -$42.9K 0.13% 66
2024
Q2
$495K Buy
17,681
+2,467
+16% +$67.9K 0.14% 59
2024
Q1
$422K Buy
15,214
+2,731
+22% +$75.8K 0.13% 64
2023
Q4
$359K Buy
12,483
+1,582
+15% +$47.8K 0.12% 64
2023
Q3
$362K Buy
10,901
+153
+1% +$5.41K 0.13% 59
2023
Q2
$394K Buy
10,748
+1,151
+12% +$44.8K 0.14% 59
2023
Q1
$392K Buy
9,597
+564
+6% +$24.4K 0.15% 59
2022
Q4
$463K Sell
9,033
-63
-0.7% -$3.02K 0.2% 55
2022
Q3
$398K Sell
9,096
-339
-4% -$16.5K 0.17% 53
2022
Q2
$495K Sell
9,435
-273
-3% -$13.9K 0.2% 50
2022
Q1
$503K Sell
9,708
-275
-3% -$14.3K 0.17% 50
2021
Q4
$590K Buy
9,983
+682
+7% +$33.8K 0.2% 51
2021
Q3
$400K Buy
9,301
+252
+3% +$11.2K 0.14% 58
2021
Q2
$354K Buy
9,049
+2,402
+36% +$93.4K 0.13% 57
2021
Q1
$241K Buy
6,647
+3,661
+123% +$130K 0.1% 59
2020
Q4
$110K Buy
2,986
+1,309
+78% +$48K 0.05% 71
2020
Q3
$58K Buy
1,677
+240
+17% +$8.41K 0.02% 87
2020
Q2
$45K Buy
1,437
+82
+6% +$2.79K 0.02% 98
2020
Q1
$42K Sell
1,355
-64
-5% -$2.18K 0.02% 94
2019
Q4
$53K Buy
1,419
+10
+0.7% +$356 0.03% 110
2019
Q3
$48K Sell
1,409
-370
-21% -$13.5K 0.03% 106
2019
Q2
$73K Sell
1,779
-225
-11% -$8.93K 0.04% 93
2019
Q1
$81K Buy
2,004
+1,141
+132% +$45.7K 0.04% 91
2018
Q4
$36K Buy
863
+354
+70% +$14.7K 0.02% 117
2018
Q3
$21K Sell
509
-46
-8% -$1.77K 0.01% 135
2018
Q2
$19K Sell
555
-18,065
-97% -$617K 0.01% 157
2018
Q1
$627K Sell
18,620
-25,861
-58% -$889K 0.37% 51
2017
Q4
$1.53M Buy
44,481
+2,570
+6% +$87.6K 0.92% 31
2017
Q3
$1.42M Buy
41,911
+1,545
+4% +$49.7K 0.92% 30
2017
Q2
$1.29M Buy
40,366
+39,506
+4,594% +$1.25M 0.81% 35
2017
Q1
$28K Buy
860
+158
+23% +$4.98K 0.02% 129
2016
Q4
$22K Sell
702
-2,167
-76% -$66.2K 0.02% 120
2016
Q3
$92K Sell
2,869
-9,102
-76% -$304K 0.08% 78
2016
Q2
$400K Buy
11,971
+10,760
+889% +$343K 0.49% 30
2016
Q1
$34K Sell
1,211
-359
-23% -$10.3K 0.05% 52
2015
Q4
$48K Buy
1,570
+119
+8% +$3.74K 0.05% 50
2015
Q3
$43K Sell
1,451
-14,295
-91% -$458K 0.06% 53
2015
Q2
$501K Buy
15,746
+10,395
+194% +$339K 0.27% 72
2015
Q1
$177K Buy
+5,351
New +$170K 0.1% 63
2014
Q4
Sell
-3,553
Closed -$100K 145
2014
Q3
$100K Buy
3,553
+2,524
+245% +$70.8K 0.06% 64
2014
Q2
$29K Sell
1,029
-114,539
-99% -$3.27M 0.02% 116
2014
Q1
$3.52M Buy
+115,568
New +$3.45M 2.23% 12

Other funds holding PFE

Winch Advisory Services's PFE Position: Q2 2026 in Review

Winch Advisory Services increased its Pfizer (PFE) stake by 0.78% in Q2 2026, buying an estimated $3.5K and bringing the position to 17,345 shares worth $418K. The position accounts for 0.09% of the portfolio, ranked #82.

Winch Advisory Services first reported a position in PFE in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.52M in Q1 2014. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Winch Advisory Services held 17,345 shares of Pfizer worth $418K as of Q2 2026.
  • Winch Advisory Services bought 134 Pfizer shares in Q2 2026, an estimated $3.5K.
  • Pfizer made up 0.09% of Winch Advisory Services's portfolio in Q2 2026, its #82 holding.
  • Winch Advisory Services first reported a position in Pfizer in Q1 2014 and has held it in 49 quarters since.
  • Winch Advisory Services's Pfizer position peaked at $3.52M in Q1 2014.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Winch Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.